- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01500356
Effect of Exercise and Weight Loss on Cardiovascular Health (Heart Health)
Study Overview
Status
Conditions
Detailed Description
Current estimates indicate that in excess of 65 percent of adults in the United States are overweight (BMI >25.0 kg/m2) with at least 30 percent of adults classified as obese (BMI >30 kg/m2). Overweight and obesity have been linked to numerous chronic conditions including cardiovascular disease. The application of cardiac MRI (CMRI) allows for direct measurement of the cardiac structure, and left ventricular mass (LVM) assessed by CMRI has been shown to be predictive of cardiovascular disease. Recent studies have shown that LVM is decreased with weight loss; however, there is a lack of information on the added benefit of physical activity to weight loss on these direct measures of cardiovascular structure and function. Thus, consistent with PA-09-243, this study will examine the effect of two recommended doses of physical activity combined with a dietary intervention on changes in the proposed outcomes of cardiovascular disease risk in overweight adults.
The primary aim of this study is to examine the effect of the consensus public health recommended level of physical activity [moderate physical activity (MOD-PA) = 150 min/wk] versus a higher dose of physical activity [high physical activity (HIGH-PA) = 250 min/wk] in the context of a comprehensive behavioral weight loss program that a includes a reduction in energy intake measures of cardiovascular function using cardiac MRI and biomarkers of vascular disease risk. Each of these exercise doses will be compared independently to a Diet Only group intervention on the proposed primary and secondary outcomes, with MOD-PA also compared to HIGH-PA. This study involves the recruitment of 390 overweight and obese adults who will be randomly assigned to one of the above conditions (Diet Only, MOD-PA, HIGH-PA) for a period of 12 months. The primary outcome is LVM measured by cardiac MRI. Secondary outcomes include additional cardiac MRI measures (aortic pulse wave velocity, end diastolic volume, aortic distensibility), inflammatory markers (CRP and TNFα) and selected adipocytokines (adiponectin) as biomarkers of risk related to vascular outcomes, body weight, body composition, and cardiorespiratory fitness, and traditional CVD risk factors (lipids, glucose, insulin, blood pressure). Additional secondary analyses will allow for examination of the effects of physical activity independent of weight change on the primary and secondary outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15260
- University of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18-55 years of age.
- Body mass index (BMI) between 25.0 to <40.0 kg/m2.
- Ability to provide informed consent prior to participation in this study.
Exclusion Criteria:
- Females who are currently pregnant or breastfeeding, or reporting that she is planning a pregnancy within the next 12 months.
- History of bariatric surgery.
- Report current medical condition or treatment for a medical condition that could affect body weight. These may include the following: cancer (Note: Persons previously diagnosed with non-melanoma skin cancers, those successfully treated for cancer who have remained disease-free for five years or more would be eligible for participation in this study); diabetes mellitus; hyperthyroidism; inadequately controlled hypothyroidism; chronic renal insufficiency; chronic liver disease; gastrointestinal disorders including ulcerative colitis, Crohn's disease, or malabsorption syndromes; etc.
- Current congestive heart failure, angina, uncontrolled arrhythmia, symptoms indicative of an increased acute risk for a cardiovascular event, prior myocardial infarction, coronary artery bypass grafting or angioplasty, conditions requiring chronic anticoagulation (i.e. recent or recurrent DVT).
- Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of >100 mmHg.
- Eating disorders that would contraindicate weight loss or physical activity.
- Alcohol or substance abuse.
- Currently treated for psychological issues (i.e., depression, bipolar disorder, etc), taking psychotropic medications within the previous 12 months, or hospitalized for depression within the previous 5 years.
- Report exercise on >3 days per week for >20 minutes per day over the past 3 months. (NOTE: It is important that individuals are sedentary when entering this study to allow for maximal effect of the intervention.)
- Report weight loss of >5% or participating in a weight reduction diet in the past 3 months.
- Report plans to relocate to a location not accessible to the study site or having employment, personal, or travel commitments that prohibit attendance to at least 80 percent of the scheduled intervention sessions and all of the scheduled assessments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Diet alone
Weight loss intervention that focuses only on reducing energy intake of the diet.
|
Weight loss intervention that focuses on reducing energy intake.
|
|
EXPERIMENTAL: Diet plus Moderate Exercise
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 150 minutes per week of moderate-intensity exercise.
|
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 150 minutes per week of moderate-intensity exercise.
|
|
EXPERIMENTAL: Diet Plus High Exercise
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 250-300 minutes per week of moderate-intensity exercise.
|
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 250-300 minutes per week of moderate-intensity exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Left ventricular mass assessed using cardiac MRI
Time Frame: Baseline (0 months) and 12 months
|
Left ventricular mass will be assessed using cardiac MRI
|
Baseline (0 months) and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in end-diastolic volume assessed using cardiac MRI
Time Frame: baseline (0 months) and 12 months
|
Assessed using cardiac MRI
|
baseline (0 months) and 12 months
|
|
Change in cardiorespiratory fitness
Time Frame: baseline (0 months) 6 months, and 12 months
|
Measured using a graded exercise test
|
baseline (0 months) 6 months, and 12 months
|
|
Change in blood levels of C-Reactive Protein (CRP)
Time Frame: baseline (0 months), 6 months, and 12 months
|
Assessed from a fasting blood sample
|
baseline (0 months), 6 months, and 12 months
|
|
Change in body weight
Time Frame: baseline (0 months), 6 months, and 12 months
|
baseline (0 months), 6 months, and 12 months
|
|
|
Change in body composition
Time Frame: baseline (0 months), 6 months, and 12 months
|
Measured using dual-energy x-ray absorptiometry (DXA)
|
baseline (0 months), 6 months, and 12 months
|
|
Change in regional adiposity
Time Frame: baseline (0 months), 6 months, 12 months
|
Measured using anthromometry that includes girth measures of the waist and hip
|
baseline (0 months), 6 months, 12 months
|
|
Change in physical activity
Time Frame: baseline (0 months), 6 months, 12 months
|
Measured using both a wearable device and by questionnaire
|
baseline (0 months), 6 months, 12 months
|
|
Change in energy intake
Time Frame: baseline (0 months), 6 months, 12 months
|
Assessed using a questionnaire
|
baseline (0 months), 6 months, 12 months
|
|
Change in traditional CVD risk factors (lipids, glucose, insulin)
Time Frame: baseline (0 months), 6 months, 12 months
|
Measured from a fasting blood sample
|
baseline (0 months), 6 months, 12 months
|
|
Change in resting blood pressure
Time Frame: baseline (0 months), 6 months, 12 months
|
baseline (0 months), 6 months, 12 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HL103646
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Behavioral weight loss intervention
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brown... and other collaboratorsRecruiting
-
University of PittsburghCompleted
-
The University of Tennessee, KnoxvilleAmerican Heart AssociationCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Cigarette Restitution FundCompletedKidney Cancer | Breast Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Melanoma (Skin) | Gallbladder CancerUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); Unrestricted research gift...Completed
-
The Miriam HospitalNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedWeight LossUnited States